| AZAvsCD3-Dn in-CD3-activated |
GPCR downstream signaling |
Pathways - Reactome.gmt GeneSets |
-6.5 |
0.0 |
207.0 |
74.0 |
43.43 |
| AZAvsIL7-Dn in-IL7-activated |
GPCR downstream signaling |
Pathways - Reactome.gmt GeneSets |
-1.7 |
0.02002 |
199.0 |
3.0 |
1.03 |
| EntryvsLatency-Up in-Resting |
GPCR downstream signaling |
Pathways - Reactome.gmt GeneSets |
-1.8 |
0.03449 |
206.0 |
19.0 |
11.71 |
| IL7vsCD3-Up in-IL7-activated |
GPCR downstream signaling |
Pathways - Reactome.gmt GeneSets |
-8.7 |
0.0 |
205.0 |
72.0 |
37.06 |
| HIVvsMockinLatency-Up in-Mock |
GPCR downstream signaling |
Pathways - Reactome.gmt GeneSets |
-4.3 |
5.0E-5 |
204.0 |
8.0 |
1.68 |
| AZAvsDISU-Up in-DISU-activated |
GPCR downstream signaling |
Pathways - Reactome.gmt GeneSets |
-1.9 |
0.01131 |
202.0 |
4.0 |
1.34 |
| DISUvsCD3-Up in-DISU-activated |
GPCR downstream signaling |
Pathways - Reactome.gmt GeneSets |
-7.0 |
0.0 |
207.0 |
68.0 |
37.48 |
| DMSOvsCD3-Up in-DMSO-activated |
GPCR downstream signaling |
Pathways - Reactome.gmt GeneSets |
-7.3 |
0.0 |
206.0 |
77.0 |
44.03 |
| SAHAvsCD3-Up in-SAHA-activated |
GPCR downstream signaling |
Pathways - Reactome.gmt GeneSets |
-7.9 |
0.0 |
212.0 |
78.0 |
43.23 |
| DMSOvsDISU-Dn in-DMSO-activated |
GPCR downstream signaling |
Pathways - Reactome.gmt GeneSets |
-2.0 |
0.00894 |
202.0 |
5.0 |
1.77 |
| DMSOvsDISU-Up in-DMSO-activated |
GPCR downstream signaling |
Pathways - Reactome.gmt GeneSets |
-2.1 |
0.00723 |
202.0 |
3.0 |
0.76 |
| EntryvsTCRReactivation-Up in-Entry |
GPCR downstream signaling |
Pathways - Reactome.gmt GeneSets |
-8.2 |
0.0 |
207.0 |
72.0 |
37.98 |
| LatencyvsTCRReactivation-Up in-Resting |
GPCR downstream signaling |
Pathways - Reactome.gmt GeneSets |
-7.7 |
0.0 |
210.0 |
97.0 |
59.76 |
Figure: : Temporal expression patterns are displayed according to the selected conditions and comparisons. Only infected conditions are displayed, during latency as gray lines or during activation according to the color code for each drug. For individual genes, select one from the table below.